Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer

Q3 Medicine

Journal of Interventional Medicine Pub Date : 2023-11-01 DOI:10.1016/j.jimed.2023.09.001

Yasaman Anbari , Floortje E. Veerman , Grace Keane , Arthur J.A.T. Braat , Maarten L.J. Smits , Rutger C.G. Bruijnen , Wenle Tan , Ye Li , Feng Duan , Marnix G.E.H. Lam

{"title":"Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer","authors":"Yasaman Anbari , Floortje E. Veerman , Grace Keane , Arthur J.A.T. Braat , Maarten L.J. Smits , Rutger C.G. Bruijnen , Wenle Tan , Ye Li , Feng Duan , Marnix G.E.H. Lam","doi":"10.1016/j.jimed.2023.09.001","DOIUrl":null,"url":null,"abstract":"<div><p>Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (<sup>90</sup>Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with <sup>90</sup>Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of <sup>90</sup>Y microspheres in the treatment of liver cancer.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":"6 4","pages":"Pages 153-159"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096360223000479/pdfft?md5=5035fae5d67492f85a90cced74213303&pid=1-s2.0-S2096360223000479-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Interventional Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2096360223000479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (⁹⁰Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with ⁹⁰Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of ⁹⁰Y microspheres in the treatment of liver cancer.

查看原文本刊更多论文

钇-90微球放射栓塞治疗原发性和转移性肝癌的现状

肝脏恶性肿瘤，包括原发性肝癌和转移性肝癌，由于恶性程度高、系统治疗策略有限，已成为全球最常见的癌症相关死亡原因之一。钇-90（90Y）负载微球放射栓塞是一种相对新颖的技术，在肝脏恶性肿瘤的局部治疗方面取得了重大进展。本文从技术和临床两方面讨论了对有 90Y 微球治疗适应症的患者进行放射性栓塞治疗的大量工作中，从患者选择到随访的不同步骤。本文介绍了 90Y 微球在肝癌治疗中的应用和发展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Interventional Medicine Medicine-General Medicine

CiteScore

1.30

自引率

0.00%

发文量

审稿时长

68 days